Clinical Trials Directory

Trials / Unknown

UnknownNCT05125757

Lifestyle Modification in Psoriatic Patients With Fatty Liver

Response of Fatty Liver to Lifestyle Modification in Psoriasis Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Male
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Several recent reports have shown an increased prevalence of nonalcoholic fatty liver disease (NAFLD) in those with psoriasis, which may reflect the increased occurrence of metabolic syndrome in this patient population.

Detailed description

the recruitment of 60 fatty live men with chronic disease, psoriasis, will be classified to lifestyle modification group (foe 12 weeks, this patients will take supervised energy or diet restriction program plus their usual immunosuppressive drugs ) and control group will continue their drug program only)

Conditions

Interventions

TypeNameDescription
OTHERlifestyle modificationfor 12 week, the patients of this group will receive their usual immuno-modulating therapy plus life style modification (energy or diet restriction in addition to daily walking, 15000 steps)
OTHERusual lifestylethe patients will receive the usual immuno-modulating therapy with continued usual diet and activities

Timeline

Start date
2021-09-13
Primary completion
2022-03-15
Completion
2022-03-15
First posted
2021-11-18
Last updated
2021-11-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05125757. Inclusion in this directory is not an endorsement.